Consequently, unraveling the underlying mechanism behind the increase in PD-L1 expression mediated by exosomal lncRNAs will expedite the identification and advancement of innovative ICIs that target these lncRNAs, revealing a promising therapeutic approach for the management of such neoplasms. This evidence concerns the gene CD274 and neoplasm.